# TR Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tr

- Industry: Healthcare IT
- Headquarters: Daejeon, South Korea
- Website: www.theresearcher.co.kr/
- Total disclosed funding: $3.3M
- Latest round: Series A (Sep 13, 2026)
- Investors on record: 7

## About

Based in Daejeon, South Korea, and founded in 2020, TR Corporation operates as a digital healthcare company specializing in developing medical devices and electronic products. In September 2026, TR Corporation raised KRW 2 billion in Series A funding from FuturePlay, Holistic Growth Initiative, and IBK Venture Investment. As of September 2026, the company is led by its CEO Byeong-su Kim. 

TR Corporation's flagship offering is Spirokit, an AI-based screening system that boasts precision akin to established lung function testers in university hospitals. It allows for convenient testing anywhere using smart devices, catering to primary and secondary medical institutions and empowering individual respiratory disease management. Additionally, it provides Mechano Tape, a domestically developed medical device, that addresses blood pooling issues, aiding joint and muscle movement.

## Funding rounds

- Series A, Sep 13, 2026, $1.5M — FuturePlay, Holistic Growth Initiative, IBK Venture Investment
- Series A, Jan 19, 2026, $1.4M — TBT Partners, IBX Partners
- Seed, Feb 1, 2022, $0.4M — Korea Tech Incubator for Startup, Mirae Holdings

## Investors

- Korea Tech Incubator for Startup — Seed
- Mirae Holdings (https://capitalatlas.ai/funds/mirae-holdings) — Seed
- TBT Partners (https://capitalatlas.ai/funds/tbt-partners) — Series A
- IBX Partners (https://capitalatlas.ai/funds/ibx-partners) — Series A
- FuturePlay (https://capitalatlas.ai/funds/futureplay) — Series A
- Holistic Growth Initiative (https://capitalatlas.ai/funds/holistic-growth-initiative) — Series A
- IBK Venture Investment (https://capitalatlas.ai/funds/ibk-venture-investment) — Series A